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Abstract: 
Botanical extracts of Echinacea purpurea have been widely used for the treatment of upper 
respiratory infections. We sought to chemically examine fungal endophytes inhabiting E. 
purpurea, and to identify compounds produced by these endophytes with in vitro cytokine-
suppressive activity. Twelve isolates from surface sterilized seeds of E. purpurea were subjected 
to fractionation and major components were isolated. Sixteen secondary metabolites belonging to 
different structural classes were identified from these isolates based on NMR and mass 
spectrometry data. The compounds were tested for their influence on cytokine secretion by 
murine macrophage-type cells. Alternariol (1), O-prenylporriolide (4), porritoxin (10) β-
zearalenol (13), and (S)-zearalenone (14) inhibited production of TNF-α from RAW 264.7 
macrophages stimulated with LPS in the absence of any significant cytotoxicity. This is the first 
report of a cytokine-suppressive effect for 4. The results of this study are particularly interesting 
given that they show the presence of compounds with cytokine-suppressive activity in 
endophytes from a botanical used to treat inflammation. Future investigations into the role of 
fungal endophytes in the biological activity of E. purpurea dietary supplements may be 
warranted. 
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Article: 
Medicinal plants retain their popularity as an important part of health care worldwide. 
The Echinaceagenus has been employed for treating rhinosinusitis, the common cold, upper 
respiratory infections, and other inflammatory conditions [1–4]. While debates over therapeutic 
effects of Echinacea abound in the literature, preparations of this multi-million dollar herb 
consistently rank among the best-selling botanicals in the United States [5], and are also very 
popular in Europe [6]. Some clinical studies have shown faster recovery from cold episodes on 
consumption of Echinacea preparations, while others suggest no useful impact [3]. 
The purported health benefits of Echinacea preparations are generally believed to occur via 
action on the immune system. In support of this, a number of in vitro studies have shown various 
immunomodulatory effects of Echinacea (reviewed in [7]). However, these studies have also 
shown confounding and often conflicting results. Echinacea extracts contain an array of different 
chemical constituents, including alkylamides, phenylpropanoids, polysaccharides, and volatile 
oils [3], which have different biological effects. Moreover, the levels of these constituents in a 
particular Echinacea product can vary depending on the species, plant parts, and/or geographical 
origin of plants used, and the method of processing [3]. Such variability may be one explanation 
for the inconsistencies reported for both clinical and in vitro studies of Echinacea preparations. 
Furthermore, the scientific community that studies botanical medicines has become increasingly 
aware of the potential importance of endophytes (microbes that reside in internal living tissues of 
plants) in altering or influencing the chemical composition of botanicals. Endophytes live in 
close association with plants, and their populations can differ depending on seasonal changes and 
geographic conditions [8, 9]. Hence, it has been proposed that the biological activity of a 
particular botanical could vary due to differences in endophyte profile. Along these lines, there is 
evidence that bacterial endophytes can alter the in vitro immunomodulatory activity 
of Echinacea and other botanicals [10, 11], and it has been shown that several bacterial 
endophytes from Echinacea possess immunomodulatory activity [12]. Several recent studies 
have demonstrated that Echinacea plants also harbor fungal endophytes [13, 14]. However, the 
potential immunomodulatory effects of these fungal endophytes or their constituents have yet to 
be evaluated. Our goals with this project were to culture and characterize fungal endophytes 
from E. purpurea seeds, isolate secondary metabolites from these endophytes, and evaluate their 
activity in vitro against RAW 264.7 murine macrophage-type cells. Our study focused on fungal 
endophytes isolated from Echinacea purpurea (L.) Moench (Asteraceae), which is the species 
most commonly cultivated for medicinal use in the United States. 
Twelve fungal isolates from surface sterilized seeds of E. purpurea (Table 1) were subjected to 
natural products chemistry. From these, 16 known fungal secondary metabolites (Table 
2 and Figure 1) were identified. These compounds were identified by comparison of their NMR 
and mass spectrometry data with literature (Table S1). 
 
Figure 1. Secondary metabolites isolated from fungal endophytes of Echinacea purpurea. 
Table 1. Fungal endophytes isolated from surface sterilized Echinacea purpurea seed tissues. 
Twelve different isolates belonging to seven different operational taxonomic units (OTUs) were 
investigated in this study. The ITS region was sequenced and used for identification with 
GenBank BLAST search. All sequences are deposited at GenBank (accession numbers below). 
The strain numbers are internal references to the fungal library at the University of North 
Carolina at Greensboro. 
Strains Fungal taxon GenBank accession number 
G327 Epicoccum nigrum KR094439 
G328 Fusarium equiseti KR094440 
G330 Phaeospheria sp. KR094442 
G332 Lewia infectoria KR094444 
G335 Lewia infectoria KR094447 
G336 Tilletiopsis pallescens KR094448 
G389 Fusarium equiseti KR094458 
G390 Epicoccum nigrum KR094459 
G391 Lewia infectoria KR094460 
G393 Alternaria sp. KR094462 
G405 Fusarium oxysporum KR094464 
G406 Lewia infectoria KR094465 
 
Table 2. Secondary metabolites isolated from fungal endophytes. All endophytes were isolated 
from surface sterilized Echinacea purpurea seeds. 
Compound # Secondary Metabolite (References) Isolate Number 
1 Alternariol [31] G330 
1 
 
G332 
1 
 
G336 
1 
 
G406 
2 9-o-Methyl-alternariol [31] G332 
3 Altenuene [32] G332 
4 O-Prenylporriolide [33] G330 
5 Terpestacin [34] G330 
6 Fusaproliferin [35] G330 
7 (S)-Curvularin [36] G330 
8 (S)-10,11-Dehydrocurvularin [36] G330 
9 Porritoxinol [37] G330 
10 Porritoxin [37] G330 
11 Equisetin [38] G328 
11 
 
G330 
11 
 
G335 
11 
 
G389 
12 5'-Epi-equisetin [39] G330 
12 
 
G389 
13 β-Zearalenol [40] G389 
14 (S)-Zearalenone [40] G389 
15 8-O-Methyl-fusarubin [41] G405 
16 Orevactaene [42] G327   
G390   
G391   
G393 
 
The 16 compounds (Table 2) were tested for cytotoxicity against RAW 264.7 cells using 
rhodamine 123, a dye that is retained by cells with intact mitochondria and lost by cells 
undergoing either apoptosis or necrosis [15]. A range of concentrations was tested, from 0.0025–
25 µg/mL, although effects were only noted at 2.5 and 25 µg/mL (Figure 2A). (S)-10, 11-
Dehydrocurvularin (8) and 8-O-methyl-fusarubin (15) caused substantial dose-dependent cell 
death, while lower but significant levels of cytotoxicity were observed with porritoxin (10), 
equisetin (11) and 5’-epi-equisetin (12). Two of the resorcylic acid lactones, β-zearalenol (13) 
and (S)-zearalenone (14), have been reported to be cytotoxic towards RAW 264.7 cells [16, 17]. 
Although we did not observe this, it is possible that it could be observed at higher doses or 
longer incubation times. 
 
Figure 2. Influence of fungal metabolites on RAW 264.7 viability and secretion of TNF-α. Cells 
were treated with fungal compounds (numbered via Table 2) at 2.5 and 25 µg/mL alone (A) or in 
the presence of 10 ng/mL LPS (B). Cytotoxicity was measured using a rhodamine 123 assay (A). 
In B, culture supernatants were collected and assayed for TNF-α levels using ELISA. Values 
shown are means of two independent experiments, each of which included duplicate biological 
replicates (total of four biological replicates). Positive controls (+) include 100 µg/mL 
cycloheximide for cytotoxicity (A) [31] and dodeca-2E,4E-dienoic acid isobutylamide for 
inhibition of TNF-α production [30] (B). Data was analyzed using a one way ANOVA with 
Tukey’s post hoc test; *=p<0.05, **=p<0.01, and ***=p<0.001. Compound 2 was not soluble at 
25 µg/mL and was tested at 1.25 and 12.5 µg/mL. 
The isolated fungal metabolites (Table 2) were also tested at the same range of concentrations for 
their ability to affect both constitutive and LPS-induced production of TNF-α. Levels of 
constitutive TNF-α production from RAW 264.7 cells were low (50–100 pg/mL), and none of 
the compounds caused statistically significant enhancement or suppression (Figure S1). In 
contrast, in the presence of 10 ng/mL LPS, production of TNF-α was robust, with 6–8 ng 
accumulating in cultures in the different experiments. For purposes of comparison, these data are 
shown as percent of control (Figure 2B). Several compounds, 1, 4, 13, and 14, demonstrated 
pronounced inhibition of LPS-induced TNF-α production in the absence of significant toxicity. 
Compounds 4 and 9 are structurally related, but compound 4 was a more potent inhibitor of 
TNF-α production. This observation suggests that the diol moiety in 9 decreases potency. 
Compound 10 produced a weak cytotoxic effect and strongly inhibited LPS-induced production 
of TNF-α, while compounds 11 and 12 also produced weak cytotoxic effects but enhanced TNF-
α production for LPS treated cells (Figure 2B). It is possible that these compounds produce an 
effect akin to activation-induced apoptosis, first acting in concert with LPS to activate the cells, 
which is followed by an apoptotic response [18]. 
Whereas studies on fungal endophytes present in other plant organs exist [13,19], this is the first 
to investigate endophytes present in E. purpurea seeds. The rationale is that fungi present in seed 
material may be transmitted vertically (from parent to progeny) and may be host-specific. 
However, it is also possible to find horizontally transmitted endophytes (originating from the 
environment) in seeds. Thus, the investigated fungi may be in therapeutic preparations, however, 
it is more common to employ root material for dietary supplements from this botanical [20]. 
Future studies of endophytes from other E. purpurea plant tissues might be of interest. 
It is notable that Echinacea purpurea preparations are commonly used to treat inflammation, and 
the cytokine-suppressive activity observed for the fungal metabolites is consistent with an anti-
inflammatory effect. Moreover, it is possible that the toxicity of several mycotoxins encountered 
in this study could influence the therapeutic properties of herbal preparations. However, the 
studied metabolites were produced by cultured endophytes. Whether they are present at 
biologically relevant concentrations to alter the toxicity or biological activity 
of Echinacea preparations is a question that would require further investigation. 
In summary, a number of compounds with in vitro cytokine-suppressive activity were isolated 
from the fungal endophytes of E. purpurea seeds. Although no new compounds were 
encountered, this is the first report of cytokine suppression by compound 4. 
Experimental 
General Instrumentation Techniques 
Optical rotations were acquired on a Rudolph Research Autopol III polarimeter. NMR 
experiments used a JEOL ECS-400 (400 MHz for 1H and 100 MHz for 13C; JEOL Ltd., Tokyo, 
Japan). HRESIMS data were collected with an electrospray ionization source coupled to a Q-ToF 
Premier mass spectrometer (Waters Corp., Milford, MA, USA) or a LTQ Orbitrap XL system 
(Thermo Fisher Scientific, San Jose, CA, USA) in positive and/or negative ionization modes by 
direct injection or via an Acquity UPLC system (Waters Corp.). A CombiFlash Rf 200 system 
using a RediSep Rf Si-gel Gold column (both from Teledyne-Isco, Lincoln, NE, USA) was 
employed for normal-phase flash chromatography. HPLC was performed via a ProStar HPLC 
system with a 335 photodiode array detector (Varian Inc., Palo Alto, CA, USA). YMC ODS-A 
(Waters Corp.; 5µm; columns of dimensions 250 × 20 mm, 250 × 10 mm, and 150 × 4.6 mm) or 
Kinetex C18 (Phenomenex; 5µm; columns of dimensions 250 × 21.2 mm and 250 × 4.6 mm) 
were used for preparative, semi-preparative, and analytical HPLC, respectively. For UPLC 
analysis, a BEH C18 (Waters Corp.; 1.7 µm; 50 × 2.1 mm) column was used. 
Endophyte Isolation 
E. purpurea seeds (lot # 6784) were obtained from Horizon Herbs, LLC (Williams, OR, USA), 
and a voucher of an E. purpurea plant from this source is deposited at the University of North 
Carolina at Chapel Hill Herbarium (NCU583422). The seeds were surface sterilized [21] and 
placed on 1.5 % water agar Petri dishes. All fungi were isolated within 14 days of culture and 
three times single spore isolated to obtain pure cultures. 
Endophyte Identification 
Axenic cultures were harvested and ground under sterile conditions using liquid nitrogen. DNA 
amplification was performed combining the primers ITS1F/ITS1 and ITS4 [22, 23] under 
defined cycling conditions [24]. PCR products were purified with a QIAquick Purification Kit 
(QIAGEN Inc., Valencia, CA, USA) and sequenced (Eurofins MWG Operon LLC, Huntsville, 
AL, USA). The sequences were manually edited and identified by BLASTn search against 
authentic sequences in GenBank. Sequences from the entire ITS region (IT1-5.8-ITS2) were 
deposited at GenBank (Table 1). 
Extraction and Isolation of Fungal Secondary Metabolites 
Methods for preparing fungal inoculum for growth on rice, and procedures for isolation of 
secondary metabolites, have been detailed [24]. Key references for the characterization of all 16 
compounds are provided as Supporting Information (Table 1S). 
Cytotoxicity Assays and Measurement of TNF-α 
Each compound was tested in duplicate experiments, performed on different days, over a range 
of concentrations (0.0025–25.0 µg/mL), with two biological replicates in each experiment (for a 
total of four biological replicates). Ethanol (1% final concentration) was used as the diluent for 
all but three compounds (1, 2, and 15) where dimethylsulfoxide (DMSO) was used (0.2% final 
concentration). The compounds were tested for toxicity using the rhodamine 123 (Rho123) 
assay. Cells were treated overnight with each secondary metabolite in 96 well plates. After 
incubation, the supernatant was removed, and Rho123 was added in the buffer for 30 min (5 µM 
final concentration), removed, and cells washed with 1× PBS [28]. The fluorescence was 
measured using a BMG FLUOstar Galaxy microplate reader (492/538) (BMG LABTECH 
GmbH, Ortenberg, Germany). For TNF-α testing, cells were treated, supernatants harvested, and 
then TNF-α measured using murine TNF-α ELISA kit purchased from eBioscience, Inc. (San 
Diego, CA). To stimulate TNF-α production, 10 ng/mL ultrapure LPS from Salmonella 
minnesota R595 (List Biological Laboratories, Inc. Campbell, CA, USA) was used. As a positive 
control for inhibition of TNF-α production, the compound dodeca-2E,4E-dienoic acid 
isobutylamide (ChromaDex, Irvine, CA, USA) was used at a concentration of 25 µg/mL. The 
cytokine-suppressive activity of this compound has been documented elsewhere [29]. 
Statistical Analysis 
Experimental results were analyzed with a one way ANOVA with Tukey’s post hoc test using 
Prism software (GraphPad Software, Inc., La Jolla, CA, USA). 
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